Konzilium s.r.o. — Clinical Trial Site

15 Registered trials

6 Currently recruiting

Organisation

Konzilium s.r.o.

Location

Nova Dubnica, Slovakia

Identifier

ORG-100048225

Address

Puskinova 795/8, 018 51, Slovakia

Departments

#40772: Neurology
#630: Neurologicka ambulancia
Medicinske centrum
N/A
Neurologicka ambulancia
Neurologická ambulancia A.Kmeťa 370/15 018 41 Dubnica nad Váhom
Neurology
psychiatricka ambulancia

Clinical trials at this site (15)

Search interface

A clinical trial to assess the safety of EXV-802 and EXV-801 and how well they work to reduce agitation symptoms in people with Alzheimer's … Pending

2024-517388-22-00 Agitation in Alzheimer's Disease Dementia 10
An Open-Label Study of ML-007C-MA in Adults with Alzheimer’s Disease Psychosis Pending

2025-521757-16-00 Hallucinations and Delusions Associated with Alzheimer’ 4
A Multicenter Open-label Extension Study to Evaluate the Long-term Safety of Cenobamate Adjunctive Therapy in Subjects with Primary Generali… Recruiting

2023-506688-32-00 Primary Generalized Tonic-Clonic Seizures 5 2019-10-09
A Study of ML-007C-MA for the Treatment of Hallucinations and Delusions Associated with Alzheimer’s Disease Psychosis Recruiting

2024-519820-26-00 Hallucinations and Delusions Associated with Alzheimer’ 4 2026-01-22
A clinical trial to evaluate efficacy and safety of Xeomin® injections for preventing chronic migraine Recruiting

2024-515682-34-00 Chronic migraine 5 2025-10-06
A clinical trial to evaluate efficacy and safety of Xeomin® injections for preventing episodic migraine Recruiting

2024-515715-22-00 Episodic migraine 5 2025-10-06
A Phase 3, Parallel Group Study to Evaluate KarXT as a Treatment for Psychosis Associated with Alzheimer’s Disease Recruiting

2024-516363-92-00 Psychosis Associated with Alzheimer’s Disease 5 2025-04-08
A study to see how well KarXT is tolerated and how well tolerated it is when taken for long time in participants with psychosis associated w… Recruiting

2023-504151-27-00 Psychosis associated with Alzheimer’s Disease 5 2024-05-09
AN INTERVENTIONAL, EFFICACY, AND SAFETY, PHASE 3 RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY WITH AN OPEN-LABEL EXTENSION TO INVESTI… Ended

2023-505601-16-00 Chronic Migraine 5 2025-04-22
A study to learn about the safety of long-term treatment with brivaracetam in children and young adults with childhood or juvenile absence e… Ended

2023-508095-11-00 Childhood Absence Epilepsy 5 2024-11-27
A dose-finding trial with LU AG90222 in adults with migraine who have not been helped by prior preventative treatments. Ended

2023-508821-28-00 Migraine 4 2024-08-14
A Randomized, Placebo-Controlled, Double-Blind Study of XPro1595 in Patients with Early Alzheimer’s Disease with Biomarkers of Inflammation Ended

2023-505396-71-00 Early Alzheimer’s Disease with Biomarkers of Inflammati 4 2024-03-01
A study to learn if brivaracetam works and is safe in children and young adults 2 to 25 years of age with childhood absence epilepsy or juve… Ended

2023-510428-55-00 Childhood Absence Epilepsy Juvenile Absence Epilepsy 10 2022-03-10
Assessment of the Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's … Ended

2023-504991-31-00 Agitation in Patients With Dementia of the Alzheimer's 5 2021-05-06
A Randomized, Double-blind, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Safety of Cenobamate Adjunctive Therapy in Su… Ended

2023-506687-13-00 Primary Generalized Tonic-Clonic Seizures 5 2019-01-31